Найкращі терапевти з лікування стаціонарного лікування (1 день) – ТОП-12 лікарів

Education:

2010 - 2016 - National Medical University named after O.O. Bogomolets, specialty "Medical business"

2017 - completed an internship in the field of "Laboratory diagnostics"

2018 - Ukrainian Military Medical Academy, specialty "Dermatovenereology"

2021 - senior lecturer of the department of VZPSM on the course "Dermatovenereology", Ukrainian Military Medical Academy  

2021 - certified trainer in injection techniques

Since 2017 - dermatologist, cosmetologist at Mediland MC

Improving skills and acquiring new knowledge:

2017 - courses under the program "Cosmetologist, body esthetician" at the School of Cosmetology and Aesthetic Medicine "Partner +"

2017 - courses under the program "Specialist in injection techniques: mesotherapy, biorevitalization, botulinum therapy, contour plastic surgery"

2017 - participant of the III All-Ukrainian symposium Company of Cosmetology

2018 - course under the "Trichology" program

2018 - course under the program "Plasmotherapy"

2018 - course under the program "Contour plastic in aesthetic medicine"

2018 - course under the program "PRX-T33 - Injection-free dermal remodeling"

2018 - received training in laser techniques "Laser training on: Motus, MINISILK_FT, YNCHRO_FT"

2018 - participant of the 4th All-Ukrainian symposium "Company of Cosmetology"

2020 - "MEDfocus: dialogue of professionals" Modern approaches in dermatology and aesthetic medicine

2020 - "DERM SUMMIT" International scientific and practical virtual summit for doctors of all specialties and patients on dermatology issues

2021 - "Melanoma days 2021"

2021- "Acne, rosacea and chronic dermatoses of the face" as part of the 2021 Spring Symposium.

2021 - "Academy of Trichology"

2021 - "S-congress 3.0"

2021 - "Advanced dermatology: multifaceted possibilities and solutions"

2022 - academic readings named after Volodymyr Pask within the framework of the 31st International Medical Exhibition "PUBLIC HEALTH 2022"

2022 - "MELANOMA DAY 2022"

Is a valid member:

Ukrainian Association of Dermatologists and Cosmetologists UADVC

International Association of Aesthetic Cosmetology and Mesotherapy MAEKM

The doctor is an expert in the TV project "I am ashamed of my body" (STB channel) - he conducts consultations, diagnoses and treats patients, the heroes of the project.

Certified trainer in injection techniques of the MedHome company for Twac and Phillex drugs.Senior lecturer of the Department of the Ukrainian Academy of Medical Sciences for the course "Dermatovenereology", Ukrainian Military Medical Academy  

A trichologist, dermatologist diagnoses and treats such diseases of the skin of the face and body, nails and hair as:

acne skin irritations, acne, postacne

rosacea

demodicosis

seborrheic dermatitis

skin neoplasms - warts, papillomas, etc

alopecia or hair loss of various types (examination using a trichoscope and laboratory tests, prescription of conservative treatment, treatment using injection methods of treatment)

onychomycosis or nail fungus

other diseases of the skin of the face, body, hair

Performed procedures for diagnosis and treatment of dermatological diseases:

Dermatoscopy

Radiowave removal of skin neoplasms with the Surgitron device

Cryodestruction of skin neoplasms - warts, papillomas

Cryomassage of the skin of the face, body and scalp

Trichoscopy of the scalp and hair follicles

The doctor will draw up an individual comprehensive skin care program depending on the type of skin and its condition

The cosmetologist performs the following procedures:

Laser cosmetology:

laser epilation

laser grinding

photo rejuvenation

carbon peeling

Classical cosmetology:

mechanical cleaning of the face

ultrasonic face cleaning

chemical peels

facial massage

carboxytherapy

skin care procedures

comprehensive skin care programs

Hardware cosmetology:

procedures on "Futura PRO"

Ultrasonic facial massage

microcurrent

myostimulation of the face and body

biostimulation of the face and body

darsonval of the face and scalp

Injection cosmetology:

mesotherapy of the face, body and scalp / hair

biorevitalization

revitalization "Aquashine"

botulinum therapy

contour plastic

plasma lifting or PRP therapy

Cryotherapy:

cryomassage of the skin of the face, décolleté, back

cryomassage of the scalp

Лікар із понад 20-річним стажем у фізичній медицині та реабілітації, в тому числі очолював відділення реабілітації та заступник завідувача відділенням реабілітації. Має сертифікат спеціаліста з алгіатрії та фізичної медицини та реабілітації, а також закінчив курси міоскелетної медицини, медичної акупунктури та фізіотерапії тазового дна. Опублікував кілька праць в галузі реабілітації.

Доктор Марк Ульріх Бехер - інтервенційний кардіолог і фахівець із серцевої недостатності. Він виконує такі операції, як коронарна ангіографія, радіочастотна абляція з 3D-картуванням, каротидна ангіопластика і стентування, а також інші.

Лікар з досвідом метаболічного контролю у хворих на цукровий діабет та гіпертонічною хворобою та дипломом діабетолога. Нинішній медичний директор GIOSTAR Mexico у Лос-Альгодонес-Мехікалі, Нижня Каліфорнія з 2017 року. Закінчив Автономний університет Гвадалахари та має досвід прийому пацієнтів, зовнішнього медичного обслуговування та невідкладної допомоги в багатьох приватних лікарнях.

Education:

1977 - 1984 - Medical Institute, specialty "Medical business"

Improving skills and acquiring new knowledge:

1990 - Clinical residency in the specialty "Cycle therapy with clinical cardiology", Kyiv

1992 - TU "Medical Radiology", Kharkiv

1995 - TU "Modern methods of diagnosis of internal diseases and rheumatology", Kyiv

1999 - TU "Organization of Medical Support of the Armed Forces", Kyiv

2004 - TU "Current issues of clinical arrhythmology in cardiology", Kyiv

2009 - TU "Current issues of therapy and rheumatology", Kyiv

2012 - TU "Fundamentals of geriatric knowledge", Kyiv

2013 – Institute for Advanced Training of Managerial Personnel of the National Academy of Sciences under the President of Ukraine, Kyiv

2014 - TU "Current issues of therapy and pulmonology", Kyiv

2016 - Specialization "organization and management of health care", Kyiv

2018 - TU "Current issues of internal diseases of the patient", Kyiv

2020 - TU "Current issues of therapy", Kyiv

2021 - TU "Current issues of internal diseases of the patient", Kyiv

2023 - TU "Current issues - clinical cardiology", Kyiv

The main areas of practical activity:

examination, anamnesis study and consultations on the treatment of diseases of a therapeutic profile

appointment of the necessary additional examination

interpretation of analysis results

appointment of an individual treatment plan and recommendations for disease prevention

control of therapy, recovery and rehabilitation measures

Participation in associations:

Association of therapists of Ukraine

Association of Cardiologists of Ukraine

Association of Gastroenterologists of Ukraine

Organization of medical care in EU countries

Association of Physiotherapists ("Karlovo Vary", Prague)

The therapist treats the following diseases:

SARS

acute bronchitis

pneumonia

State Public Enterprise

acute vasomotor rhinitis

chronic gastroduodenitis

ulcer disease

chronic cholecystitis

pancreatitis

NCD

hypertensive disease

CHD

gout

gouty polyarthritis

acute cystitis

metabolic disorders, obesity

Experience

2018 - 2022

Health Sciences University – Şişli Hamidiye Etfal Training and Research Hospital

2016 - 2018

Diyarbakır Memorial Dicle Hospital Cardiology Clinic

2010 - 2010

Dicle University Faculty of Medicine, Department of Cardiology

2010 - 2016

Private Veni Vidi Hospital, Cardiology Clinic Supervisor

2006 - 2010

Dicle University Faculty of Medicine, Department of Cardiology

2005 - 2006

Urfa State Hospital

1999 - 2005

Turkey High Specialization Training and Research Hospital

1998 - 1999

Duruca Health Center

Education

2018

Health Sciences University, Cardiology

2010

Dicle University, Department of Cardiology

2005

Cardiology Turkey High Specialization Training and Research Hospital, Medical Specialization

1998

Ege University, Faculty of Medicine

Experience

2019 - 2022

University of Health Sciences, Faculty of Medicine, Ankara City Hospital, Cardiology Clinic, Ankara

2017 - 2019

University of Health Sciences, Faculty of Medicine, Turkey Higher Specialization Training and Research Hospital, Cardiology Clinic, Ankara,

2012 - 2017

Türkiye Higher Specialization Training and Research Hospital, Cardiology Clinic, Ankara,

2012 - 2017

T.R. Karabük University, Faculty of Medicine, Department of Cardiology

2006 - 2006

Türkiye Higher Specialization Training and Research Hospital, Cardiology Clinic, Ankara,

2001 - 2006

Türkiye Higher Specialization Training and Research Hospital, Cardiology Clinic, Ankara,

1996 - 2001

Türkiye Higher Specialization Training and Research Hospital, Cardiology Clinic, Ankara,

Education

2017 Karabük University, Faculty of Medicine, Department of Cardiology

2006 Türkiye Higher Specialization Training and Research Hospital, Cardiology Clinic

2001 Türkiye Higher Specialization Training and Research Hospital, Ankara, Cardiology

1996 Ankara University, Faculty of Medicine

PROFESSIONAL EXPERIENCE

2011-2012
Erzurum Koprukoyu State Hospital
Department: General Medicine

2012-2017
Istanbul University Cerrahpaşa Medical Faculty
Department: Internal Medicine

06/2017-10/2017
Istanbul Gaziosmanpasa Taksim Training and Research Hospital
Department: Internal Medicine

10/2017-11/2018
Istanbul University Istanbul Medical Faculty
Department: Allergy and Immunology Fellowship

2018/2022
Istanbul University Oncology Institute
Department: Medical Oncology Fellowship

2022-2023
Tekirdag City Hospital
Department: Medical Oncology Specialist

2023-present
Istanbul Medipol University Medipol Bahcelievler Private Hospital
Department: Medical Oncology Assoc. Prof.

EDUCATION

2005-2011
Medical Education
Sivas Cumhuriyet University Medical Faculty, Sivas, Turkey

2012-2017
Internal Medicine
Istanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey

2017-2018
Allergy-Immunology Fellowship
Istanbul University Istanbul Medical Faculty
Department of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey

2018-2022
Medical Oncology Fellowship
Istanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey

2022
ESMO Board Certification in Medical Oncology
10th September 2022 in Paris, France.

2023
Medical Oncology Assoc. Prof.
Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey

INTERNATIONAL CLINICAL TRIALS:

1. Astefania - ROCHE

• Title: A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
• Role: Subinvestigator

2. PFİZER

• Title: A Study Of Lorlatinib Versus Crizotinib In First-Line Treatment Of Patients With ALK-Positive NSCLC
• Role: Subinvestigator

3. RECITE - AMGEN

• Title: Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer
• Role: Subinvestigator

4. NAVIGATE - BAYER

• Title: A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors
• Role: Subinvestigator

5. RUBY - Tesaro (PRA)

• Title: A Phase 3, Randomized, Double-blind, Multicenter Study of Dostarlimab (TSR-042) Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Patients With Recurrent or Primary Advanced Endometrial Cancer
• Role: Subinvestigator

6. ENGOT-ov43/GOG-3036 - MSD

• Title: Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK001/ENGOT-ov43/GOG-3036)
• Role: Subinvestigator

7. ASTRA ZENECA

• Title: To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.
• Role: Subinvestigator

8. ROSY-O - ASTRA ZENECA

• Title: Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib
• Role: Subinvestigator
•  

INTERNATIONAL PUBLICATIONS

I. Published journal articles indexed by SCI, SSCI, and AHCI

Weekly Paclitaxel in Classic Kaposi Sarcoma

• Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Ahmed, M. A., Karaman, S., & Aydiner, A.
• Journal: Medicine, 102(5)

Carboplatin Desensitization in Ovarian Carcinoma

• Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Yildiz, A., Ak, N., & Aydiner, A.
• Journal: Medicine, 101(45), e31726

High-Dose Chemotherapy for Ewing’s Sarcoma

• Authors: Paksoy, N., Ferhatoglu, F., Dogan, İ., Khanmammadov, N., Celik, A. I., Gulbas, Z., & Başaran, M.
• Journal: Medicine, 101(49), e32213

Multidrug Refractory TFE3(+) Renal Cell Carcinoma

• Authors: Paksoy, Nail, et al.
• Journal: Journal of Oncology Pharmacy Practice, 2022, 28.1: 215-221

Crizotinib Efficacy in NSCLC with MET Alterations

• Authors: Gürbüz, M., Kiliçkap, S., Bilici, A., Karadurmuş, N., Sezer, A., Şendur, M. A. N., ... & Demirkazik, A.
• Journal: Medicine, 101(50), e32368

Clinicopathological Features in ALK Mutant NSCLC

• Authors: Dogan, I., Gurbuz, M., Paksoy, N., Ferhatoglu, F., Vatansever, S., Saip, P., ... & Aydiner, A.
• Journal: Medicine, 101(34)

PSMA-Based Tumor Burden in Prostate Cancer

• Authors: HAS SIMSEK, Duygu, et al.
• Journal: Annals of Nuclear Medicine, 2021, 35.6: 680-690

Atezolizumab in Metastatic Urothelial Carcinoma

• Authors: TURAL, Deniz, et al.
• Journal: European Urology Focus, 2021, 7.5: 1061-1066

Pulmonary Sarcomatoid Carcinoma

• Authors: FERHATOGLU, Ferhat, et al.
• Journal: Oncology Research and Treatment, 2021, 44.11: 590-601

Prognostic Factors in Atezolizumab-Treated Urothelial Carcinoma

• Authors: TURAL, Deniz, et al.
• Journal: International Journal of Clinical Oncology, 2021, 26.8: 1506-1513

Atezolizumab with Chemotherapy in Small Cell Lung Cancer

• Authors: GÜRBÜZ, Mustafa, et al.
• Journal: Journal of Cancer Research and Clinical Oncology, 2022, 1-9

FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic Cancer

• Authors: AY, Seval, et al.
• Journal: Journal of Chemotherapy, 2022, 1-7

Trastuzumab Emtansine in Older HER2-Positive Breast Cancer Patients

• Authors: CIL, Ibrahim, et al.
• Journal: Tumori Journal, 2022, 108.1: 19-25

Real-Life Efficacy of Osimertinib in Advanced NSCLC

• Authors: HIZAL, Mutlu, et al.
• Journal: Journal of Cancer Research and Clinical Oncology, 2022, 148.6: 1501-1508

ALK-Positive Cells Percentage and Alectinib Efficacy

• Authors: Hizal, M., Bilgin, B., Paksoy, N., Atcı, M. M., Kahraman, S., Kılıçkap, S., ... & Şendur, M. A. N.
• Journal: Journal of Cancer Research and Clinical Oncology, 149(8), 4141-4148

Real-World Data on Alectinib in ALK-Positive NSCLC

• Authors: Hizal, M., Bilgin, B., Paksoy, N., Kılıçkap, S., Atcı, M. M., Kahraman, S., ... & Şendur, M. A. N.
• Journal: Future Oncology, 18(23), 2573-2582

Prognostic Factors in Metastatic RCC with T790M Mutation

• Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in Metastatic Gastric Cancer

• Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
• Journal: Journal of Cancer Research and Therapeutics

Desensitization Protocol in Lenalidomide Hypersensitivity Reactions

• Authors: DEMIR, Semra, et al.
• Journal: Annals of Allergy, Asthma & Immunology, 2019, 123.4: 394-397

Factors Associated with Diagnostic Skin Test Positivity in PPI Hypersensitivity

• Authors: ÖZDEMIR, Seçil Kepil, et al.
• Journal: Allergy, 2019, 74.6: 1187-1190

Efficacy of Capecitabine and Temozolomide in Neuroendocrine Tumors

• Authors: Ünal, Ç., Azizy, A., Karabulut, S., Taştekin, D., Akyıldız, A., Yaşar, S., ... & Sağlam, S.
• Journal: The Oncologist, oyad257

Subsequent Treatments in Hormone-Positive Breast Cancer Progression

• Authors: Karacin, C., Oksuzoglu, B., Demirci, A., Keskinkılıç, M., Baytemür, N. K., Yılmaz, F., ... & Hacıbekiroğlu, İ.
• Journal: BMC cancer, 23(1), 192

Termination of Trastuzumab in HER2-Positive Metastatic Breast Cancer

• Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Saip, P., & Aydiner, A.
• Journal: Scientific Reports, 13(1), 8779

Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast Cancer

• Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Ferhatoğlu, F., Ak, N., ... & Aydiner, A.
• Journal: Journal of Cancer Research and Clinical Oncology, 1-9

Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast Cancer

• Authors: Doğan, İ., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydıner, A.
• Journal: European Journal of Breast Health, 19(2), 128

Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast Cancer

• Authors: Kahraman, S., Erul, E., Seyyar, M., Gumusay, O., Bayram, E., Demirel, B. C., ... & Nahit Sendur, M. A.
• Journal: Future Oncology, 19(10), 727-736

Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma Patients

• Authors: Dogan, I., Paksoy, N., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

Single-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma Patients

• Authors: Dogan, I., Paksoy, N., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

Outcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain Metastases

• Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in First-Line Treatment of Metastatic Gastric Cancer

• Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
• Journal: Journal of Cancer Research and Therapeutics

Prognostic Factors of Perioperative FLOT Regimen in Operable Gastric Cancer

• Authors: Erol, C., Sakin, A., Basoglu, T., Ozden, E., Cabuk, D., Dogan, M., ... & Sendur, M. A. N.
• Journal: [Not specified]

Efficacy and Outcomes of Systemic Chemotherapy in Posttransplant Kaposi Sarcoma

• Authors: Khanmammadov, N., Paksoy, N., Doğan, I., Ferhatoğlu, F., Saip, P., & Aydiner, A.
• Journal: Medicine, 102(39), e35383

Comparison of Second-Line Treatments in Metastatic Renal Cell Carcinoma

• Authors: Pehlivan, M., Paksoy, N., Aydin, E., Basaran, M., & Ekenel, M.
• Journal: Medicine, 102(41), e35245

Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)

Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)

Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.

Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49

Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4

Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.

Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY

Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of Pulmonology

Laterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)

Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)

Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)

Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)

Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye

Thesis:

Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)

International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)

Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination

• Authors: Dogan, I., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydiner, A. (2022)

Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study

• Authors: Şenocak Taşçi, E., Oyan, B., Sonmez, O., Mutlu, A. U., Atcı, M. M., Oner, I., ... & Gulmez, A. (2022)

Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancer

• Authors: Dogan, I., Aydin, E., Paksoy, N., Ferhatoglu, F., Ak, N., Ibis, K., ... & Aydiner, A. (2021)

Efficacy of temozolomide in pretreated patients with metastatic sarcoma

• Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors

• Authors: Ferhatoglu, F., Paksoy, N., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma

• Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases

• Authors: Dogan, İ., Iribas, A., Paksoy, N., Ekenel, M., Vatansever, S., & Basaran, M. (2021)

Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma

• Authors: Tural, D., Olmez, O. F., Sümbül, A. T., Artac, M., Ozhan, N., Akar, E., ... & Erman, M. (2021)

Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study

• Authors: Esin, E., Ahmed, M. A., Yıldırım, H. Ç., Mandel, N. M., Erdemoglu, E., Sari, M., ... & Paydas, S. (2023)

Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiences

• Authors: Tural, D., Ölmez, Ö. F., Sümbül, A. T., Artaç, M., Özhan, N., Akar, E., ... & Kılıçkap, S. (2021)

Професор Маркус Дюкс — спеціаліст у галузі діагностичної радіології та малоінвазивної терапії.

Нагороди

• Золота медаль почесного професора медичного університету в Осаці (Японія).
• Почесний член DeGIR (Німецького товариства інтервенційної радіології та мінімально інвазивної терапії).

Освіта та професійний досвід

• 1982-1988 – вивчення медицини людини в Університеті Йоханнеса-Гутенберга в Майнці.
• 1988 - апробація та медична ліцензія.
• 1988-1989 – медичний офіцер Бундесвера.
• 1990 - кандидат у доктора медичних наук у галузі радіології, предмет: "Дослідження впливу швидкості дилатації на її успіх, а також на пошкодження стінок судини при розширенні балона", в Університеті Йоханнеса-Гутенберга в Майнці.
• 1990-1996 - ординатор відділення променевої діагностики в університеті імені Рупрехта та Карла.
• 1996 - старший лікар відділення радіодіагностики в Гейдельберзькому університеті імені Рупрехта та Карла.
• 1998 - докторський ступінь у галузі "Діагностична радіологія", тема: "Методи візуалізації карциноми шлунка в прямому порівнянні: значення оптимізованих методів обстеження в клінічній практиці та перший досвід експерименту з магнітно-резонансною томографією".
• 2000 - заступник завідувача відділення променевої діагностики, кафедра радіодіагностики в Гейдельберзькому університеті ім. Рупрехта Карла.
• 2000-2002 – керівник центру обробки зображень ортопедичної клініки університету Гейдельберг.
• 2002-2003 - завідувач відділення променевої діагностики, хірургічна клініка, відділення променевої діагностики у Гейдельберзькому університеті ім. Рупрехта Карла.
• 2003 - головний лікар Центрального інституту радіології та нейрорадіології клініки Нордвест у Франкфурті-на-Майні.
• 2006 - ад'юнкт-професор відділення радіології у Гейдельберзькому університеті.

Наукова діяльність

Маркус Дюкс — один із перших терапевтів, які виконали мінімально інвазивну мікрохвильову абляцію пухлин печінки та легень під контролем КТ.

Клінічна діяльність

Професор очолює перший та єдиний у Рейн-Майнському регіоні Центр ФУЗ абляції під контролем МРТ. У більшості випадків процедура дозволяє уникнути хірургічного втручання. Пацієнтам центру доступна абляція при раку простати, метастазах у кістках та печінці, доброякісних новоутвореннях, лікування міоми матки без хірургічного втручання.

Членство в організаціях

• DRG (Німецьке товариство рентгенологів).
• DeGIR (Німецьке суспільство інтервенційної радіології та мінімально інвазивної терапії).
• RSNA (Радіологічне суспільство Північної Америки).
• ESGAR (Європейське суспільство шлунково-кишкової та абдомінальної радіології).
• CIRSE (Серцево-судинне та інтервенційне радіологічне суспільство Європи).
• ECR (Європейський конгрес з радіології).
• EUFUS (Європейське товариство ФУЗ-терапії).
• MEDICA (Німецьке товариство міждисциплінарної медицини).